IP Library Granted Patent US 8,975,231
Granted Patent B2
US 8,975,231 · App. 13/486,498 · Granted Mar 10, 2015

Bone morphogenic protein binding peptide

Inventors: Samuel S. Murray (Saugus, CA); Elsa J. Brochmann-Murray (Saugus, CA); Jeffrey Wang (Sherman Oaks, CA); Keyvan Behnam (Simi Valley, CA)
Assignees: The Regents of the University of California; The United States of America represented by the Department of Veterans Affairs
C07K7/08A61K38/1875C07K14/51A61K38/1841
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,975,231
App. No.
13/486,498
Granted
Mar 10, 2015
Kind
B2
Abstract

A cyclized peptide designated BMP Binding Peptide (BBP) is a synthetic peptide that avidly binds rhBMP-2, as do endogenous forms of BBP, and sequence conservation between species results in a variety of useful BBP compositions. BBP increases the over-all osteogenic activity of rhBMP-2, increases the rate at which rhBMP-2 induces bone formation, and BBP induces calcification alone. Compositions and substrates including BBP, and methods of using BBP are useful in therapeutic, diagnostic and clinical applications requiring calcification and osteogenesis.

Claims (5)

1. A method of inducing osteogenesis or calcification in vertebrate tissue comprising administering to the tissue chondrogenic or osteogenic precursor cells and a peptide having the amino acid sequence of SEQ ID NO. 13, or a fragment thereof, wherein said peptide or fragment increases the degree or rate of osteogenesis or calcification.

2. The method of claim 1 wherein the chondrogenic or osteogenic precursor cells are administered to the tissue at a location proximate to the desired location of calcification.

3. The method of claim 1 further comprising administering one or more of TGF-beta, BMP-2, BMP-4, BMP-7 or demineralized bone matrix.

4. The method of claim 1 wherein the chondrogenic or osteogenic precursor cells secrete one or more growth factors.

5. The method of claim 4 wherein the growth factor is a TGF-beta family member.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2013
From: MURRAY, SAMUEL S.; MURRAY, ELSA J.; BEHNAM, KEYVAN; WANG, JEFFREY
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA; UNITED STATES GOVERNMENT REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Reel/Frame 031210/0245 →
Continuity (4)
Continuation 11985745 · Nov 16, 2007
Continuation In Part 10587313
Provisional Application 60539903 · Jan 28, 2004
Related Publication 20130095139A1 · Apr 18, 2013